Atea Pharmaceuticals, Inc. (AVIR) Stock Total Returns
Growth of $10,000 chart
2021-04-14 to 2026-04-14 to
$
%
%
Loading chart…
Investment Performance
Final Value
$1,063
Total Return
-89.37%
CAGR
-36.14%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | -0.83% |
| Median | -1.90% |
| Best | +55.70% |
| Worst | -74.48% |
| % of Windows Positive | 42.9% |
1-Year (252 Trading Days)
| Average | -21.36% |
| Median | -23.72% |
| Best | +115.61% |
| Worst | -88.00% |
| % of Windows Positive | 27.9% |
3-Year (756 Trading Days)
| Average | -51.15% |
| Median | -57.07% |
| Best | +84.61% |
| Worst | -93.15% |
| % of Windows Positive | 8.0% |
Risk Metrics
| Maximum Drawdown | -95.33% |
| Average Drawdown | -87.17% |
| Drawdown Duration | 1255 Trading Days (Unrecovered) |
| Sortino Ratio | -0.38 |
| Calmar Ratio | -0.38 |
| CVaR (5%) | -9.04% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +62.47% (+449.79% ann.) | +$6246.58 | $0.00 | $0.00 | $0.00 |
| 2025 | +6.57% | +$656.70 | $0.00 | $0.00 | $0.00 |
| 2024 | +9.84% | +$983.62 | $0.00 | $0.00 | $0.00 |
| 2023 | -36.59% | $3659.08 | $0.00 | $0.00 | $0.00 |
| 2022 | -46.20% | $4619.66 | $0.00 | $0.00 | $0.00 |
| 2021 | -78.60% | $7860.22 | $0.00 | $0.00 | $0.00 |
| 2020 partial | +37.71% (+558.55% ann.) | +$3770.60 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Policy bazooka / monetary euphoria partial | October 30, 2020 – November 6, 2020 | +12.62% | +49325.22% | +$1262.36 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -70.26% | -68.35% | $7025.79 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -41.41% | -43.31% | $4140.94 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -21.18% | -12.05% | $2117.67 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 14, 2026 | +45.36% | +26.93% | +$4536.31 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.